Western blot

ES Edilene Siqueira
AO Aida Obiols-Guardia
OJ Olga C. Jorge-Torres
CO Cristina Oliveira-Mateos
MS Marta Soler
DR Deepthi Ramesh-Kumar
FS Fernando Setién
DR Daniëlle van Rossum
AP Ainhoa Pascual-Alonso
CX Clara Xiol
CI Cristina Ivan
MS Masayoshi Shimizu
JA Judith Armstrong
GC George A. Calin
RP R. Jeroen Pasterkamp
ME Manel Esteller
SG Sonia Guil
request Request a Protocol
ask Ask a question
Favorite

20 mg of mouse FC or HIP and human postmortem HIP were resuspended in Laemmli buffer (2% SDS, 10% glycerol, 60 mM Tris-Cl [pH 6.8], and 0.01% bromophenol blue), sonicated, and boiled for 5 min at 95°C. The sample concentration was determined by quantifying the absorbance at 260 nm with a NanoDrop One/OneC Microvolume UV spectrophotometer and using the equivalency between DNA and histone quantity (6 units A260nm [DNA] = 1 μg/μL of protein). Proteins were transferred to a 0.2-μm nitrocellulose membrane (10600001, GE Healthcare, Chicago, IL, USA) and incubated overnight at 4°C with a primary antibody diluted in 5% skim milk in PBS containing 0.1% Tween 20 (663684B, Atlas Chemical, Houston, TX, USA). After three washes with PBS containing 0.1% Tween 20, membranes were incubated for 1 h at RT in a benchtop shaker with the secondary antibodies conjugated to horseradish peroxidase anti-rabbit IgG (1:10,000, A0545; Sigma-Aldrich, St. Louis, MO, USA) or anti-mouse IgG (1:5,000; NA9310, GE Healthcare, Chicago, IL, USA). Enhanced chemiluminescence (ECL) reagents (Luminata-HRT; Merck Millipore, Burlington, MA, USA) were used to visualize the proteins. Films were scanned, and the band analysis tool of the Quantity One software application was used for background subtraction and to determine the density of the bands. The proteins detected were MeCP2 (1:1,000; ab2829, Abcam, Cambridge, UK), SIRT2 (1:2,000; ab211033, Abcam, Cambridge, UK), acetyl-α-tubulin (1:2,000; T6793, Sigma-Aldrich, St. Louis, MO, USA), α-tubulin horseradish peroxidase (HRP) (1:5,000; ab40742, Abcam, Cambridge, UK), β-actin HRP (1:30,000; a3854, Sigma-Aldrich, St. Louis, MO, USA), TAU (1:1,000; ab64193, Abcam, Cambridge, UK), MAP6/STOP (1:1,000; 4265, Cell Signal, Danvers, MA, USA), STMN1 (1:500; 3352, Cell Signal, Danvers, MA, USA), S100b (1:1,000; Z0311, Dako, Carpinteria, CA, USA), GluR-1 (1:1,000; ab109450, Abcam, Cambridge, UK), GluR-2 (1:1,000, 13607, Cell Signal, Danvers, MA, USA), GluR-3 (1:2,000; 4676, Cell Signal, Danvers, MA, USA), acetyl-lysine (1:1,000; ab80178, Abcam, Cambridge, UK), ADAR2 (1:400; HPA018277, Atlas Antibodies, Bromma, Sweden), SOX2 (1:1,000; 3579, Cell Signal, Danvers, MA, USA), and Ki67 (1:1,000; ab16667, Abcam, Cambridge, UK).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A